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Abstract
Background: Our aim was to identify the preoperative computed tomographic (CT) characteristics most efficient in
predicting overall survival (OS) of patients with maxillary cancer (MC).
Methods: A retrospective review of CT images was performed in 115 patients with histopathologically confirmed
primary MC from January 2005 to December 2013, who were classified into 2 subtypes (epithelial and non-epithelial)
according to tissue of origin. The prognostic value of CT characteristics for OS was determined firstly through
univariate Kaplan-Meier survival estimates with log-rank tests. Significant predictors were further tested with
multivariable Cox proportional hazard models.
Results: CT characteristics predictive of OS in univariate survival analysis were long and short diameter of the
mass, long and short diameter of the largest cervical lymph node and adjacent soft tissue infiltration (P < 0.05).
In the multivariable Cox analyses, the significantly independent predictors were long diameter of mass ≥ 4.2 cm
(hazard ratio [HR] 1.8; 95 % confidence interval [CI] 1.1–3.0) and short diameter of the largest lymph node ≥ 7 mm
(HR 1.9; 95 % CI 1.0–3.6) for all MC patients, as well as for non-epithelial MC patients (HR 3.1; 95 % CI 1.2–8.0; HR
3.3; 95 % CI 1.3–8.7, respectively).
Conclusions: Preoperative CT characteristics of tumor size, lymph node size and adjacent structure infiltration are
predictive of the OS time of MC patients. The information brought up in this study could be used in clinical
practice to inform about the possible prognosis, and be beneficial to clinical decision making.
Keywords: Computed tomography, Overall survival, Maxilla, Cancer
Background
According to the annual report on status of cancer col-
lected by the National Central Cancer Registry (NCCR) of
China, approximately 39,450 new cases of oral cavity can-
cer were diagnosed in 2011, with 16,933 deaths occurring
annually [1]. Estimated 5-year survival for primary oral
cavity cancer was 71 % between 2003 and 2009, varying
from 32.2 to 90.2 % depending on cancer location [2]. To
date, no nationwide overall survival (OS) data for maxil-
lary cancer (MC) has been reported in China and other
countries. Cancers located in the maxilla may originate
from odontogenic structures or jawbone, constituting
from a broad histopathological spectrum of lesions, either
epithelial or non-epithelial [3, 4]. Diversity in tissue of ori-
gin and exceedingly low prevalence bring difficulties in
differential diagnosis and prognostic prediction.
Currently, computed tomography (CT) is the primary
cross-sectional imaging tool clinically used to direct diag-
nosis, guide therapy and monitor treatment response of
jaw lesions. Preoperative imaging would be used to inform
about the possible prognosis, and is beneficial to clinical
decision making. So far, the predictive value of CT vari-
ables for patient survival has been confirmed in invasive
bladder cancer [5], lung cancer [6], hepatocellular carcin-
oma [7], and esophageal cancer patients [8]. Nevertheless,
no relative studies have been conducted concerning utility
of CT characteristics in predicting prognosis of patients
with MC. Therefore, in the current study, we reviewed the
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patients from a retrospective database at our institution to
evaluate overall survival time of MC patients and to inves-




Our study retrospectively collected patients with patho-
logically proved MC, who underwent preoperative CT
scan and received treatment in our institution from
January 2005 to December 2013. Patients were excluded
if they (1) received treatment (surgery or chemoradia-
tion) for the cancer before CT scan; (2) had a previously
diagnosed head and neck cancer; or (3) CT images could
not be obtained or interpreted. The medical records of
patients were reviewed and the following information
was retrieved for analyses: age, gender, smoking status,
alcohol use, histopathological results, TNM staging, and
treatments. Patients were defined as “ever smokers,” if
they smoked at least 100 cigarettes in their lifetime, and as
“never smokers” otherwise. “Ever drinkers” were defined
as those who drunk at least one alcoholic beverage per
week for at least one year, and as “never drinkers” other-
wise [9]. We further classified the patients into 2 subtypes
according to the tissue of origin: epithelial and non-
epithelial, by referring to the pathological classification
published by the World Health Organization in 2005 [10].
The institutional review board of Shanghai Ninth People’s
Hospital approved this retrospective study.
CT Acquisition and analyses
In this study a 64-row helical CT system (Philips Brilliance,
Philips Medical Systems, Best, the Netherlands) was used.
Prior to treatment, the patients underwent CT examin-
ation within 1 week. The scanning parameters were
120–140 kV, 200–300 mA, 23 cm field of view, 256 ×
256 matrix, and 5 mm section thickness. The patients
were injected with iopamidol (Iopamiro 320, Bracco,
Milan, Italy) or iopromide (Ultravist 300, Schering,
Germany) at a dose of 1.5 mL/kg body weight by a
power injector at a rate of 2.5 mL/s.
CT images were evaluated with Centricity Radiology RA
600 (version 6.1, GE Healthcare, Milwaukee, WI, USA) by
three radiologists (Y.Y., Y.W. and X.T.) with more than
5 years of experience in head and neck radiology. All re-
viewers were blinded to histopathologic results. For con-
tinuous variables, the average of three radiologists’
measurements was adopted, including tumor size (long
diameter of the mass [LM] and short diameter of the mass
[SM]), lymph node size (long diameter of the largest cer-
vical lymph node [LLN] and short diameter of the largest
cervical lymph node [SLN]), CT value (CT value on plain
image [plCT], CT value on contrast enhanced image
(ceCT), and increase of CT value [inCT = ceCT - plCT];
by drawing 15–20 mm2 circular region of interest [ROI]
on the most prominently enhanced portion of the mass).
Each continuous variable was converted to binary vari-
ables with cutoff value of median for statistical analyses.
Qualitative CT characteristics were also included and
evaluated by consensus, including margin (well-defined
[more than two-thirds of the margin was sharply de-
marcated]/ill-defined [less than one-third of the margin
was sharply defined] [11]), cortical involvement (with/
without maxillary cortical destruction) and soft tissue
infiltration (with/without adjacent soft tissue infiltra-
tion [muscle, fat, or neurovascular structures]).
Statistical analysis
The OS time was calculated from the preoperative CT
examination date until death from any cause or the last
follow-up date (Oct. 1, 2015). The prognostic value of CT
characteristics for OS was determined through univariate
Kaplan-Meier survival estimates with log-rank tests. Sig-
nificant predictors were then tested with multivariable Cox
proportional hazard models, and stratified analyses accord-
ing to tissue origin. The estimated hazard ratio (HR) and
95 % confidence interval (CI) was adjusted for potential
confounding effects, such as age, gender, smoking status,
alcohol use, stage and treatments. Statistical analyses were
carried out with STATA version 10.0 (College Station, TX).
P < 0.05 was considered as statistically significant.
Results
Patients and clinical characteristics
A total of 115 patients (46 male, 69 female; mean age
50.0 ± 18.5 years) with histopathologically confirmed MC
were reviewed, including 67 patients with epithelial MC
(58.3 %) and 48 patients with non-epithelial MC (41.7 %).
Pathologic diagnoses were as follows: squamous cell car-
cinoma (n = 26), osteosarcomas (n = 16), adenoid cystic
carcinoma (n = 15), myofibroblastic sarcoma (n = 10),
mucoepidermoid carcinoma (n = 7), ameloblastic carcin-
oma (n = 5), chondrosarcoma (n = 5), ghost cell odonto-
genic carcinoma (n = 3), malignant mixed tumor (n = 3),
myoepithelial carcinoma (n = 3), spindle cell carcin-
oma (n = 3), undifferentiated high grade pleomorphic
sarcoma (n = 3), adenocarcinoma (n = 2), Ewing’s sarcoma
(n = 2), lymphoma (n = 2), malignant melanoma (n = 2),
malignant peripheral nerve sheath tumor (n = 2), plasma-
cytoma (n = 2), giant cell carcinoma (n = 1), malignant fi-
brous histiocytoma (n = 1), malignant solitary fibrous
tumors (n = 1) and rhabdomyosarcoma (n = 1). The clin-
ical characteristics of patients are summarized in Table 1.
Effect of tissue of origin on OS
A total of 53 patients died during follow-up. The median
follow-up time was 50 months (range: 2–121 months).
The OS of all patients were 89.6 % (95 % CI: 82.4–93.9 %)
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at 1 year, 64.8 % (55.2–72.8 %) at 3 years and 55.4 %
(45.4–64.2 %) at 5 years. The OS of epithelial MC patients
at 1, 3 and 5 years were 91.0 % (81.2–95.9 %), 69.5 %
(56.8–79.2 %) and 60.4 % (47.0–71.4 %); while the OS for
non-epithelial MC patients were 87.5 % (74.3–94.2 %),
58.3 % (43.1–70.7 %) and 48.4 % (33.4–62.0 %), respect-
ively. The Kaplan-Meier curves of OS for all MC patients,
epithelial MC patients and non-epithelial MC patients are
presented in Fig. 1. The OS rate of epithelial MC patients
was higher than that of non-epithelial MC; however, no
statistical difference was found (P > 0.05).
Association of TNM staging and CT Characteristics with OS
We retrospectively collected the TNM staging data ac-
cording to clinical records of these patients. Kaplan-Meier
survival curves for T stage (high versus low), N stage (high
versus low) and M stage (M0 versus M1) were respectively
evaluated. As shown in Fig. 2, we did not find significant
effects of T and N stage on OS except for M stage. A sta-
tistically worse OS was experienced by M1 stage patients
(P = 0.0379), while no statistical difference was found be-
tween patients with high and low T or N stages (P > 0.05).
For CT characteristics, each continuous variable was con-
verted into binary variables with medians as cutoff value
(variable: LM, cutoff: 4.2 cm; SM, 3.0 cm; LLN, 12 mm;
SLN, 7 mm; plCT, 40 Hounsfield unit [HU]; ceCT,
62HU; inCT, 20HU). In univariate log-rank analyses,
a statistically worse OS was experienced by the pa-
tients with masses presenting adjacent soft tissue
infiltration (P = 0.0001), LM ≥ 4.2 cm (P = 0.0072), SM ≥
3.0 cm (P = 0.0058), LLN ≥ 12 mm (P = 0.0411), and
SLN ≥ 7 mm (P < 0.0001), respectively. A total of 115
(100 %) and 112 (97.4 %) MCs demonstrated ill-defined
margin and cortical destruction; therefore, no survival
Table 1 Demographics and preoperative CT characteristics of
MC patients (n = 115)





< 50 55 (47.8)











Low (T0-1) 45 (39.1)
High (T2-4) 70 (60.9)
N stage 0.7059
Low (N0-1) 79 (68.7)









< 4.2 56 (48.7)
≥ 4.2 59 (51.3)
SM (cm) 0.0058
< 3.0 60 (52.2)
≥ 3.0 55 (47.8)
LLN (mm) 0.0411
< 12 56 (48.7)
≥ 12 59 (51.3)
SLN (mm) <0.0001
< 7 55 (47.8)
≥ 7 60 (52.2)
plCT (HU) 0.4641
< 40 56 (48.7)
Table 1 Demographics and preoperative CT characteristics of
MC patients (n = 115) (Continued)
≥ 40 59 (51.3)
ceCT (HU) 0.0883
< 62 57 (49.6)
≥ 62 58 (50.4)
inCT (HU) 0.2441
< 20 58 (50.4)
≥ 20 57 (49.6)
Soft tissue infiltration 0.0001
Yes 86 (74.8)
No 29 (25.2)
C chemotherapy, CI confidence interval, CT computed tomography, HR hazard
ratio, HU Hounsfield unit, LLN long diameter of the largest cervical lymph
node, LM long diameter of the mass, MC maxillary cancers, S surgery, SLN
short diameter of the largest cervical lymph node, SM short diameter of the
mass, X radiotherapy
*P values of log-rank test for all MC patients
Bold number means statistically significant
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analyses were conducted on these two variables. The
plCT, ceCT and inCT showed no significant predictive
value (P > 0.05). The univariate log-rank results of CT
characteristics for OS are summarized in Table 1. Kaplan-
Meier curves of the significant CT predictors for OS are
shown in Fig. 3a-e.
For multivariable Cox proportional hazard models, we
first determined the main effects of significant predictors
acquired from univariate log-rank analyses (continuous
variables [LM, DM, LLN and SLN]; qualitative charac-
teristics [adjacent soft tissue infiltration]) in all MC pa-
tients, and then stratified the data according to the
tissue origin. As shown in Table 2, LM (HR 1.8; 95 % CI
1.1–3.0) and SLN (HR 1.9; 95 % CI 1.0–3.6) remained
significant predictors in all MC patients, as well as in
non-epithelial cancers (HR 3.1; 95 % CI 1.2–8.0; HR 3.3;
95 % CI 1.3–8.7, respectively). For patients with epithelial
MC, none of the five CT characteristics were found pre-
dictive to overall death. Specifically for epithelial MC, our
multivariable Cox proportional hazard models showed
that the treatment, N stage and M stage were associated
with OS (Table 3). Furthermore, the patients with
SLN ≥ 7 mm were more likely to have higher T stages
(OR, 2.3; 95 % CI, 1.0–4.8) (Table 4). Approximately
69.5 %, 33.9 % and 15.3 % of patients with LM ≥ 4.2 cm
were diagnosed with high T stage, high N stage and M1
stage, respectively; while 70.0 %, 31.7 % and 16.7 % of
patients with SLN ≥ 7 mm having high T stage, high N
stage and M1 stage, respectively.
Discussion
The MCs may share clinical characteristics but have dif-
ferent prognoses [12]. CT is the primary imaging modality
for preoperative evaluation of MC; however no report is
available on the predictive value of CT findings on MC pa-
tients’ survival. Therefore, we attempted to find predictive
factors for OS in MC patients using both quantitative and
qualitative CT characteristics. The continuous variables,
such as diameters of the mass (LM and SM), diameters of
the largest cervical lymph node (LLN and SLN) and CT
value (plCT, ceCT and inCT), are included because they
are easily measured parameters and more reliable than
others such as the imaging diagnosis of lymph node me-
tastasis. Qualitative CT variables, such as margin, cortical
involvement and adjacent soft tissue infiltration, are also
clinically acceptable and easy to assess. Since almost all
patients demonstrated ill-defined margin (100 %) and
cortical destruction (97.4 %), no survival analyses were
conducted with these two variables.
In the current study, univariate log-rank analysis
showed that LM and SM were associated with OS of
MC patients. A statistically worse OS was experienced
Fig. 1 Kaplan-Meier curve of overall survival for MC patients according to tissue of origin
Fig. 2 Kaplan-Meier curves of overall survival for T stage, N stage, and M stage. Low T stage: T0-1; high T stage: T2-4; low N stage: N0-1; high N stage: N2-3
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by the patients with preoperative LM ≥ 4.2 cm and SM ≥
3.0 cm. The multivariate Cox analysis confirmed that
LM was the independent prognostic factor in all MC pa-
tients, particularly in non-epithelial MC. The predictive
value of tumor size has been previously discussed in
lung adenocarcinoma using cutoff values of 20, 30, 50
and 70 mm with a mean tumor size of 28.9 mm [6], in
solitary small hepatocellular carcinoma with a mean
tumor size of 26–27 mm [7], and in locally advanced
esophageal cancer which used a median cutoff value of
10 mm [8]. Although with varied tumor location, path-
ology, stage, statistical method and cutoff threshold, the
previous studies exclusively proved the predictive value
of tumor size. We adopted the medians of continuous
CT variables to be cutoff values. The larger median
tumor size in our study could probably be attributed to
Fig. 3 Kaplan-Meier curves of overall survival for CT characteristics: a long diameter of the tumor, b short diameter of the tumor, c long diameter
of the largest cervical lymph node, d short diameter of the largest cervical lymph node, and e adjacent soft tissue infiltration
Table 2 Multivariable analyses of CT characteristics for OS
Characteristics All MC patients (n = 115) Epithelial MC (n = 67) Non-epithelial MC (n = 48)
n (%) P value HRa (95 % CI) n (%) P value HRa (95 % CI) n (%) P value HRa (95 % CI)
LM (cm) 0.022 1.8 (1.1-3.0) 0.392 1.4 (0.7-2.9) 0.017 3.1 (1.2-8.0)
< 4.2 56 (48.7) 34 (50.7) 22 (45.8)
≥ 4.2 59 (51.3) 33 (49.3) 26 (54.2)
SM (cm) 0.334 1.26 (0.8-2.0) 0.623 1.2 (0.6-2.7) 0.432 1.4 (0.6-3.1)
< 3.0 60 (52.2) 35 (52.2) 25 (52.1)
≥ 3.0 55 (47.8) 32 (47.8) 23 (47.9)
LLN (mm) 0.450 1.2 (0.7-2.0) 0.087 1.9 (0.9-3.8) 0.514 0.8 (0.4 ~ 1.6)
< 12 56 (48.7) 30 (44.8) 26 (54.2)
≥ 12 59 (51.3) 37 (55.2) 22 (45.8)
SLN (mm) 0.047 1.9 (1.0-3.6) 0.693 1.2 (0.6-2.5) 0.014 3.3 (1.3-8.7)
< 7 55 (47.8) 28 (41.8) 27 (56.3)
≥ 7 60 (52.2) 39 (58.2) 21 (43.8)
Soft tissue infiltration 0.984 1.0 (0.5-2.1) 0.994 1.0 (0.6-1.7) 0.862 1.1 (0.4-2.9)
Yes 86 (74.8) 51 (76.1) 35 (72.9)
No 29 (25.2) 16 (23.9) 13 (27.1)
CI confidence interval, CT computed tomography, HR hazard ratio, LLN long diameter of the largest cervical lymph node, LM long diameter of the mass, MC
maxillary cancers, SLN short diameter of the largest cervical lymph node, SM short diameter of the mass
aAdjusted for potential confounding effect, such as age, gender, smoking status, alcohol use, stage and treatments
Bold number means statistically significant
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the obscurity of the cancer, misdiagnosis as other oval
cavity diseases in early stage, and the lack of physical
checkup for jaw lesions. The cutoff points of the pre-
operative tumor size as a predictor is yet to be decided
to make it widely applicable.
The most appropriate cutoff of preoperative nodal size
for predicting patient’s survival also remains controver-
sial. Generally, lymph node size below 10 mm in short
axis is conventionally considered non-pathologic [13].
However, other diagnostic criteria were also suggested.
In a meta-analysis of head and neck cancer, size of meta-
static lymph node was suggested as larger than 12 mm
on CT [14]. Kawaguchi et al. adopted diameter ≥ 8 mm
as a positive criterion of nodal metastasis on preopera-
tive CT in gastric cancer patients [15, 16]. In the current
study, we choose to adopt the median lymph node
diameters as cutoff value instead of 10 mm in short
diameter, which is a criteria for metastatic diagnosis but
not for survival prediction. The univariate analysis showed
that a statistically worse OS was experienced by patients
with LLN ≥ 12 mm and SLN ≥ 7 mm. The multivariate
analyses further proved SLN as an independent prognostic
factor in patients with MC and in non-epithelial MC.
Schmid et al. [5] adopted 5 mm and 10 mm cutoffs of
lymph node size for patients with invasive bladder cancer.
Zhang et al. [8] used a cutoff value of 10 mm for short
diameter of the largest lymph node. Although different
cutoff values were adopted, these studies inevitably dem-
onstrated that preoperative nodal size on CT could predict
the long-term prognosis of cancer patients. These findings
suggest that the preoperative nodal status on CT is im-
portant for predicting prognosis and deciding therapeutic
strategies.
The TNM staging system could be used for an esti-
mate of prognosis in oral cancer patients [17]; however,
significantly different survival rates were only observed
in patients with M1 versus M0 stage in the current study,
but not for different T and N stage. We did find that
patients with SLN longer than 7 mm were 2.3 times
more likely to have a higher T stage than those with
SLN < 7 mm, while no association of LM and SLN with
TNM classification was found. To be noted in the
current study, all MC patients have significant OS differ-
ences based on LM and SLN, particularly prominent in
non-epithelial MC patients; however, no predictive value
of LM, SM, LLN, SLN and adjacent soft tissue infiltra-
tion status was found in epithelial MC patients. We have
further performed analysis to compare the differences of
SLN and LM between the epithelial and non-epithelial
MC patients, however, no significant difference was found
between the two subgroups for these two variables. There-
fore, it is likely that other, as-yet-unknown factors may dif-
ferently affect the survivals in both subgroups. Another
explanation could be due to the small sample size, which
could bias our estimates of association. Moreover, the
Table 3 Multivariable analyses of clinial and CT characteristics
for OS in epithelial MC patients (n = 67)
Variable P value HR (95 % CI)
age 0.858 0.9 (0.5-1.9)
gender 0.437 0.7 (0.4-1.6)
smoking 0.929 1.0 (0.4-3.0)
alcohol 0.806 0.9 (0.3-2.7)
treatment 0.049 1.8 (1.0-3.3)
T stage 0.618 0.7 (0.2-2.5)
N stage 0.023 2.8 (1.2-6.7)
M stage 0.028 2.9 (1.1-7.7)
soft tissue infiltration 0.458 1.4 (0.6-3.2)
LM 0.933 1.0 (0.5-2.4)
SM 0.157 1.9 (0.8-4.6)
LLN 0.234 1.6 (0.8-3.2)
SLN 0.779 1.1 (0.5-2.5)
CI confidence interval, CT computed tomography, HR hazard ratio, LLN long
diameter of the largest cervical lymph node, LM long diameter of the mass,
MC maxillary cancers, SLN short diameter of the largest cervical lymph node,
SM short diameter of the mass
Bold number means statistically significant
Table 4 Association between TNM stage and CT Characteristics of LM and SLN in MC patients
CT
characteristics













OR (95 % CI)
LM
≥ 4.2 cm 18 (40.0) 41 (58.6) 2.1(.99- 4.5) 39 (49.4) 20 (55.6) 1.3 (0.6-2.8) 50 (50.0) 9 (60.0) 1.5 (0.5-4.5)
< 4.2 cm 27 (60.0) 29 (41.4) 40 (50.6) 16 (44.4) 50 (50.0) 6 (40.0)
SLN
≥ 7 mm 18 (40.0) 42 (60.0) 2.3 (1.0-4.8) 41 (51.9) 19 (52.8) 1.0 (0.5-2.3) 50 (50.0) 10(66.7) 2.0 (0.6-6.3)
< 7 mm 27 (60.0) 28 (40.0) 38 (48.1) 17 (47.2) 50 (50.0) 5 (33.3)
CI confidence interval, CT computed tomography, OR odds ratio, LLN long diameter of the largest cervical lymph node, LM long diameter of the mass, MC
maxillary cancers
Low T stage: T0-1; high T stage: T2-4; low N stage: N0-1; high N stage: N2-3
Bold number means statistically significant
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estimated HRs could be also biased for overall MC pa-
tients and each of subgroups because of relatively small
numbers of patients in each groups. Therefore, large stud-
ies are needed to confirm our findings. We did perform
additional analyses restricted to epithelial cancer patients;
and we found that the treatment, N stage and M stage did
affect OS in this subgroup of patients. However, such a
significant association was found only in 67 patients of
epithelial cancers; and this finding needs to be validated in
future larger studies.
Although we have confirmed the prognostic value of
CT characteristics in MC patients, our study exhibits
several limitations. First of all, the study design was retro-
spective and the data were obtained from a single institu-
tion, therefore requiring prospective and multicenter
validation. Secondly, inter-observer differences in imaging
assessment should be taken into account, which is usually
evaluated by kappa statistic [18]. In the present study, to
rule out the possible confounding from inter-observer
differences, the average of three radiologists’ measure-
ments was used for continuous variables, while the assess-
ment of qualitative CT characteristics was conducted by
consensus. The third possible limitation was the method
used to configure the optimal cutoff value. As mentioned
above, though with similar results, the cutoff values
differed among studies. Except for the median of continu-
ous variable as we adopted, several other approaches such
as “minimum P-value approach.” [19], receiver operating
characteristic curve and the Youden index [20, 21] are
also statistically applicable. In addition, other parameters
such as the total number of lymph nodes [8], total diam-
eter of enlarged lymph nodes [21], metastatic nodal counts
[16], and lymphadenopathy [6] have also been evaluated.
Therefore, multicenter studies on larger sample size or
system reviews deserve to be conducted to acquire more
consistent and clinically applicable cutoffs and standards.
Conclusions
In conclusion, preoperative CT imaging data on tumor
size, lymph node size, and adjacent structure infiltration
were possible predictive factors for OS of MC patients.
Long diameter of the mass and short diameter of the lar-
gest cervical lymph node were independent prognostic
factors in all MC, particularly in non-epithelial MC pa-
tients. The information from this study could be included
when designing future preoperative monograms, and be
used in clinical practice to inform patients’ prognosis.
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